Long Term Survival Benefits of Different Conduits Used in Coronary Artery Bypass Graft Surgery- A Single Institutional Practice Over 20 Years
DOI: https://doi.org/10.2147/jmdh.s461567
2024-04-08
Journal of Multidisciplinary Healthcare
Abstract:Aziz Momin, 1 Redoy Ranjan, 1, 2 Oswaldo Valencia, 1 Adam Jacques, 3 Pitt Lim, 4 David Fluck, 3 Tuan P Chua, 5 Venkatachalam Chandrasekaran 1 1 Department of Cardiac Surgery, St George's University Hospitals NHS Foundation Trust, London, UK; 2 Department of Cardiac Surgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh; 3 Department of Cardiology, Ashford and St Peter's Hospitals NHS Foundation Trust, London, UK; 4 Department of Cardiology, St George's University Hospitals NHS Foundation Trust, London, UK; 5 Department of Cardiology, Royal Surrey NHS Foundation Trust, London, UK Correspondence: Aziz Momin, Consultant Cardiac Surgeon, St George's University Hospitals NHS Foundation Trust, London, SW17 0QT, United Kingdom, Tel +447956336739, Email Objective: This study determined hazard factors and long-term survival rate of total arterial coronary artery bypass graft surgery over 20 years in an extensively large, population-based cohort. Methods: A total of 2979 patients who underwent isolated CABG from April 1999 to March 2020 were studied in 4 groups- Group-A (bilateral internal mammary artery ± radial artery), Group-B (single internal mammary artery + radial artery ± saphenous vein), Group-C (single internal mammary artery ± saphenous vein; no radial artery), and Group-D (radial artery ± saphenous vein; no internal mammary artery). The study endpoints analysed the correlation between the number and types of grafts with the survival time following isolated CABG surgery. Results: The total arterial revascularization (Group A) group had an admirable mean long-term survival of ~19 years, compared to 18.6 years (Group B), 15.86 years (Group C), and 10.99 years (Group D). A Kaplan-Meier curve demonstrated confidence interval (CI) for study groups- (95% CI 18.33– 19.94), (95% CI 18.14– 19.06), (95% CI 15.40– 16.32), and (95% CI 9.61– 12.38) in Group A, B, C, D respectively. In the Holm-Sidak method analysis, significant associations existed between the number of arterial grafts and the long-term outcome. A statistically significant (P≤ 0.05) long-term survival advantage for arterial grafting was demonstrated, especially total arterial revascularisation over all other combinations except single internal mammary artery + radial artery grafting. Conclusion: In this series, over 20 years, total arterial CABG use has excellent long-term survival, achieving complete myocardial revascularisation. There is no significant difference between the BIMA group and SIMA with radial artery. However, there is a reduced survival with decreased use of arterial conduits. Keywords: coronary artery bypass graft, CABG, bilateral internal mammary artery, total arterial CABG, long term outcome, multiple arterial graft, mortality, survival benefits Coronary artery bypass graft (CABG) surgery is the preferred revascularisation strategy for multivessel coronary artery disease (CAD). 1,2 However, there is significant evidence in the literature that the type of conduits is directly related to graft patency rate and potentially influences the long-term surgical outcome. 2,3 Graft failure or loss of graft patency is not directly linked to early postoperative mortality but is associated with recurrent angina, reoperation, and poor health-related quality of life. 2–5 Recently published research articles and meta-analyses demonstrated that CABG with total arterial revascularisation (TAR), especially bilateral mammary and radial grafts, have better longevity and superior postoperative outcomes than venous grafts. A total arterial revascularisation strategy reduces postoperative morbidity, particularly in early graft failure rate, recurrent angina, and redo-CABG surgery. 3–6 The left internal mammary artery (LIMA) has a superior long-term graft patency rate and has been well-established over the last 25 years. 4–8 However, bilateral internal mammary artery (BIMA) graft in CABG is still under evaluation, especially regarding long-term graft patency and survival benefits. Only about 10% of European patients are revascularized with BIMA grafts. The Arterial Revascularisation Trial (ART), a multicentre RCT study, compared survival benefits between a bilateral internal mammary artery (BIMA) versus a single internal mammary artery (SIMA) and failed to demonstrate the superiority of BIMA after ten years of follow-up. 9 However, the ART investigators concluded that radial graft to the left coronary system and optimized medical management in conjunction with SIMA graft to the LAD territory had similar outcomes to BIMA grafts, and surgeons could avoid certain -Abstract Truncated-
health care sciences & services